Gulf Cooperation Council
Dec 04, 2019
The Regulatory process for drug approval in the MENA region
The MENA (the Middle East and North Africa) region is mostly an untouched market, which is an impetus for potential development and lucrative growth in the pharmaceutical market. The MENA region, a gamut of 22 countries, represent about 2% of the world’s pharmaceutical market. Out of which, Saudi Arabia, a country ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
